ENG
Coronary Stents Market Size, Share, segmentation and Industry Analysis Forecast (2025-2032)
Coronary Stents Market was Valued at USD 8.3 Bn. in 2024 and the total revenue is expected to grow at CAGR of 7.6% from 2025 to 2032 Reaching nearly USD 14.91 Bn. by 2032
Format : PDF | Report ID : SMR_2685
The Coronary Stents Market Overview:
Coronary Stents are expandable tubular metallic devices which are introduced into coronary arteries that are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.
The global market for coronary stent experiences steady growth, driven by the climb
Prevalence of cardiovascular diseases (CVDs) increases percutaneous coronary intervention(PCI) procedures and advances in stent technology. Medical Stent (Dec)
dominate the market because of their lower restore speed, while only metal tones (BMS) are Witness declining demand. Bioresorbable vascular scaffolding (BV) and double therapy -stones(DTS) appear as innovative alternatives, and aims to improve patient results. Key
Factors such as fuel for market expansion include the aging population, increasing risk factors such as diabetes and hypertension, and increasing adoption of minimally invasive procedures. Large regulatory approvals, high costs for stents and concerns for stent Thrombosis poses challenges for market growth. Regularly leading North America market Due to advanced health care infrastructure, while the Asia Pacific is the fastest growing region, powered by increasing health expenses and increasing patient awareness.
Big players such as Medtronic, Abbott, Boston Scientific and Terumo continue to invest in R&D for next Generation tents. Future trends include biodegradable stents, nanotechnology based coating and artificial intelligence -driven procedural planning, which ensures continued market Evolution and improved patient care.
According to Volza's data, India is the leading global importer of coronary stents, accounting for 68% of worldwide imports with 153,095 shipments between March 2023 and February 2024. The primary exporting countries to India are Ireland, Germany, and Mauritius, with Ireland contributing 58% of India's total coronary stent imports.
To get more Insights: Request Free Sample Report
The Coronary Stent Market Dynamics:
High Incidence of Obesity and Diabetes to Drive the Coronary Stents Market
More than one billion people worldwide are thicker with numbers to grow due to inactive lifestyle and unhealthy diets. Obesity and diabetes are two major risk factors to develop heart disease. According to a report by the Disease Control and Prevention Centre (C.D.C.), obesity was 42.4% in adults. As the global event of these conditions is increasing, there is a demand for stent placement processes. Obesity and diabetes manufacture panel in the arteries, and other cardiovascular diseases. This panel build-up may eventually lead to heart attack and other serious complications, which may require stent placement processes.
Therefore, the high prevalence of obesity and diabetes demands coronary stents. Importance of increasing awareness about heart disease and demand for preventive care drives for stent placement procedures. U.S.A. Preventive Services Task Force recommended that all adults between the ages of 40 and 75, who increase the risk of heart disease, are examined for high cholesterol and blood pressure. Screening programs and educational initiatives are helping to detect people who are at risk of heart disease development, seeking stent placement processes.
High Cost Procedure to Restrain the Coronary Stents Market
The costs associated with coronary stent procedures are still a significant barrier for market growth. One of the biggest restrictions facing the Coronary Stent market is the high cost of stent placement procedures. These procedures can be expensive, especially in countries with limited health services, which can limit the patient's access to stent placement as a treatment option. In addition, the high costs of procedures can push health professionals and payers to limit access to certain types of stents or limit the number of procedures performed.
Technological Advancement in Stent Design to Drive Coronary Stent Market
Innovations in bioresorable stents and drug stents with the improvement of polymer cost and next generation set technological expand the market. These advances produce improved patient results, reduces the rest of the rest of and faster recovery and leading adoption. Rapid economic growth and increasing health care and investment in emerging markets such as India, China and Brazil are the creative new opportunities. Collaboration and partnerships between stent producers and health professionals provide an opportunity for manufacturers to develop products that are better tailored for patients' needs. By working closely with health professionals, manufacturers can better understand patients' needs and develop products that are optimized for specific patient population. In addition, collaboration can help reduce the cost of stent placement procedures, making them more accessible to patients in need.
Coronary Stents Market Segmentation
Based on Type segment the Coronary Stents market is segmented into Drug Eluting Stents, Bare metal Stents, Bioresorable Stents and Covered Stents. Drug Eluting Stent Dominated the market 2024 and is expected to hold the largest Coronary stent market Share over the forecast period. Bioresorbable coronary tents, are an innovative innovation in stubborn technology. Unlike traditional metallic stents, it is designed to be absorbed by the body over time, leaving no permanent foreign material at the back of the artery. In August 2024, an article in frontiers in bioengineering and biotechnology examined bio -sorperable polymer coated stents for the treatment of coronary artery perpetrations and neointimal hyperplasia. The study highlighted the performance of different polymers, revealing that polylactide -rolactone membranes showed promise despite increased thrombogenicity. The authors emphasized the need for further preclinical studies that better replicate clinical conditions.
Based on the Biomaterial Type the Coronary Stents market is segmented into metallic, polymeric, and natural biomaterial. And The metallic biomaterial segment dominated the market in 2024 and is expected to hold the largest market share in forecast period. This wave is driven by the increasing adoption of biodegradable polymers in drug related stents and advances in polymer -based coating technologies. These innovations aim to improve biocompatibility and reduce long -term complications associated with permanent implants.
Based on the End User the Coronary Stent market is segmented into Hospitals, Ambulatory surgical centres, Cardiac Centres. and Hospital segment dominated the market in 2024 and is expected to hold the largest market share in forecast period. It is expected to grow at the fastest CAGR over the forecast period, primarily because of the growing trend of performing optional stent placements in less invasive environments. With progress in stent technologies such as drug-related stents and bio absorbable scaffolding, many coronary interventions can be safely performed in outpatient environments. These procedures involve shorter recovery times, lower costs and fewer patients, and contribute to increased demand for outpatient care. In April 2024, an article was presented at the American College of Cardiology 73. Annual scientific session that discharges the same day after optional PCI procedures is increasingly common and safe, with a low degree of retreat.
Coronary Stent market Analysis by Region:
North America
The North America coronary stents industry is dominated the market with a 43.6% market share in 2024, and is expected to hold the largest market share in forecast period driven by a high prevalence of cardiovascular diseases, advancements in medical technology, and a well-established healthcare infrastructure. The demand is fuelled by a large aging population, growing healthcare awareness, and strong reimbursement policies. March 2024 article in WIREs Nano-medicine and Nano-biotechnology discussed the significant role of nanotechnology in enhancing coronary stents, which had been vital in treating atherosclerosis. The review highlighted advancements such as Nano-coating’s that improved drug delivery, stent properties, and various nanoparticle-based formulations for local drug delivery. It also addressed the potential cytotoxic effects and hypersensitivity reactions associated with nanoparticle delivery in these medical devices.
Coronary Stent Market Competitive landscape:
The competitive landscape analysis provides adequate details on the major competitors that are prevailing in the market environment. The comparison is performed based on the company overview, the overall potential of the market, investment in R&D, total revenue generated, market initiatives, company financials, strengths and weaknesses, production sites and facilities, production capacity, etc. ex Abbott and Boston Scientific Corporation laboratories are leaders in the medical technology industry, each with unique strengths. Abbott's diverse portfolio and global range position it well in various health segments, while Boston Scientific focus on minimally invasive devices and robust R&D investment drives its growth in specialized areas. Both companies continue to innovate and adapt to market challenges, maintaining strong positions in the global health scenario.
|
Coronary Stent Market Scope Table |
|
|
Market Size in 2024 |
USD 8.3 Bn. |
|
Market Size in 2032 |
USD 14.91 Bn. |
|
CAGR (2025-2032) |
7.6% |
|
Historic Data |
2019-2024 |
|
Base Year |
2024 |
|
Forecast Period |
2025-2032 |
|
Segments |
By Type Drug Eluting Stents Bare-Metal Stents Bio resorable Stents Covered Stent |
|
By End User Hospitals Ambulatory Surgical Centres Cardiac Centres |
|
|
By Biomaterial Metallic Biomaterial Polymeric Biomaterial Natural Biomaterial |
|
|
|
By Regional North America Asia Pacific Europe Middle East America South America |
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, South Korea, Japan, India, Australia, Indonesia, Philippines, Malaysia, Vietnam, Thailand, Rest of Asia Pacific. Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Key Players in Coronary Stents Market:
North America
- Abbott Laboratories (U.S.)
- Boston Scientific Corporation (U.S.)
- Medtronic plc (Ireland, operates heavily in the U.S.)
- C. R. Bard, Inc. (U.S.)
- Cook Medical (U.S.)
- BD (Becton, Dickinson and Company) (U.S.)
- Stryker Corporation (U.S.)
- Elixir Medical Corporation (U.S.)
- InspireMD (U.S.)
- Micell Technologies, Inc. (U.S.)
- Reva Medical, Inc. (U.S.)
- XTENT, Inc. (U.S.)
Europe
- BIOTRONIK SE & Co. KG (Germany)
- B. Braun Melsungen AG (Germany)
- STENTYS SA (France)
- Translumina GmbH (Germany)
- Eurocor GmbH (Germany)
- amg International GmbH (Germany)
- Arterial Remodeling Technologies (France)
- Aachen Resonance GmbH (Germany)
- eucatech AG (Germany)
- Fortimedix B.V. (Netherlands)
- Veryan Medical (UK)
Asia Pacific
- Terumo Corporation (Japan)
- MicroPort Scientific Corporation (China)
- Biosensors International Group, Ltd. (Singapore)
- Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Meril Life Sciences Pvt. Ltd. (India)
Middle East America
- Medinol Ltd. (Israel)
Frequently Asked Questions
The Drug Eluting Segmented Accounted for the highest market share.
One of the imperative drivers is the increasing prevalence of cardiovascular diseases, including obesity and diabetes, which have become a global health concern.
The CAGR for the Coronary Stents Market Is 7.6%
There are several major companies involved in the global coronary stents market, including Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Biosensors International Group, Ltd., Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical LLC, Cardinal Health, Inc., and Stents SA, among others
1. Coronary Stent Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Coronary Stent Market: Competitive Landscape
2.1. Ecosystem Analysis
2.2. SMR Competition Matrix
2.3. Competitive Landscape
2.4. Key Players Benchmarking
2.4.1. Company Name
2.4.2. Business Segment
2.4.3. End-user Segment
2.4.4. Revenue (2024)
2.4.5. Company Locations
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Coronary Stent Market: Dynamics
3.1. Coronary Stent Market Trends by Region
3.1.1. North America Coronary Stent Market Trends
3.1.2. Europe Coronary Stent Market Trends
3.1.3. Asia Pacific Coronary Stent Market Trends
3.1.4. Middle East and Africa Coronary Stent Market Trends
3.1.5. South America Coronary Stent Market Trends
3.2. Coronary Stent Market Dynamics
3.2.1. Global Coronary Stent Market Drivers
3.2.2. Global Coronary Stent Market Restraints
3.2.3. Global Coronary Stent Market Opportunities
3.2.4. Global Coronary Stent Market Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Trade Analysis
3.5.1. Top 10 Importing Countries
3.5.2. Top 10 Exporting Countries
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis for Lubricants Industry
4. Coronary Stents: Global Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
4.1. Coronary Stent Market Size and Forecast, By Type (2024-2032)
4.1.1. Drug Eluting Stents
4.1.2. Bare-Metal Stents
4.1.3. Bio resorable Stents
4.1.4. Covered Stent
4.2. Coronary Stent Market Size and Forecast, By End User (2024-2032)
4.2.1. Hospitals
4.2.2. Ambulatory Surgical Services
4.2.3. Cardiac Centres
4.3. Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
4.3.1. Metallic Biomaterial
4.3.2. Polymeric Biomaterial
4.3.3. Natural Biomaterial
4.4. Coronary Stent Market Size and Forecast, by Region (2024-2032)
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. Middle East and Africa
4.4.5. South America
5. North America Coronary Stent Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
5.1. North America Coronary Stent Market Size and Forecast, By Type (2024-2032)
5.1.1. Drug Eluting Stents
5.1.2. Bare-Metal Stents
5.1.3. Bio resorable Stents
5.1.4. Covered Stent
5.2. North America Coronary Stent Market Size and Forecast, By End User (2024-2032)
5.2.1. Hospitals
5.2.2. Ambulatory Surgical Services
5.2.3. Cardiac Centres
5.3. North America Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
5.3.1. Metallic Biomaterial
5.3.2. Polymeric Biomaterial
5.3.3. Natural Biomaterial
5.4. North America Coronary Stent Market Size and Forecast, by Country (2024-2032)
5.4.1. United States
5.4.1.1. United States Coronary Stent Market Size and Forecast, By Type (2024-2032)
5.4.1.1.1. Drug Eluting Stents
5.4.1.1.2. Bare-Metal Stents
5.4.1.1.3. Bioresorable Stents
5.4.1.1.4. Covered Stent
5.4.1.2. United States Coronary Stent Market Size and Forecast, By End User (2024-2032)
5.4.1.2.1. Hospitals
5.4.1.2.2. Ambulatory Surgical Services
5.4.1.2.3. Cardiac Centres
5.4.1.3. United States Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
5.4.1.3.1. Metallic Biomaterial
5.4.1.3.2. Polymeric Biomaterial
5.4.1.3.3. Natural Biomaterial
5.4.1.4. Canada Coronary Stent Market Size and Forecast, By Type (2024-2032)
5.4.1.4.1. Drug Eluting Stents
5.4.1.4.2. Bare-Metal Stents
5.4.1.4.3. Bioresorable Stents
5.4.1.4.4. Covered Stent
5.4.1.5. Canada Coronary Stent Market Size and Forecast, By End User (2024-2032)
5.4.1.5.1. Hospitals
5.4.1.5.2. Ambulatory Surgical Services
5.4.1.5.3. Cardiac Centres
5.4.2. Canada Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
5.4.2.1.1. Metallic Biomaterial
5.4.2.1.2. Polymeric Biomaterial
5.4.2.1.3. Natural Biomaterial
5.4.3. Mexico
5.4.3.1. Mexico Coronary Stent Market Size and Forecast, By Type (2024-2032)
5.4.3.1.1. Auto transfusion system
5.4.3.1.2. Drug Eluting Stents
5.4.3.1.3. Bare-Metal Stents
5.4.3.1.4. Bioresorable Stents
5.4.3.1.5. Covered Stent
5.4.3.2. Mexico Coronary Stent Market Size and Forecast, By End User (2024-2032)
5.4.3.2.1. Hospitals
5.4.3.2.2. Ambulatory Surgical Services
5.4.3.2.3. Cardiac Centres
5.4.3.3. Mexico Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
5.4.3.3.1. Metallic Biomaterial
5.4.3.3.2. Polymeric Biomaterial
5.4.3.3.3. Natural Biomaterial
6. Europe Coronary Stent Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
6.1. Europe Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.2. Europe Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.3. Europe Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4. Europe Coronary Stent Market Size and Forecast, by Country (2024-2032)
6.4.1. United Kingdom
6.4.1.1. United Kingdom Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.1.2. United Kingdom Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.1.3. United Kingdom Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.2. France
6.4.2.1. France Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.2.2. France Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.2.3. France Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.3. Germany
6.4.3.1. Germany Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.3.2. Germany Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.3.3. Germany Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.4. Italy
6.4.4.1. Italy Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.4.2. Italy Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.4.3. Italy Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.5. Spain
6.4.5.1. Spain Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.5.2. Spain Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.5.3. Spain Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.6. Sweden
6.4.6.1. Sweden Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.6.2. Sweden Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.6.3. Sweden Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.7. Austria
6.4.7.1. Austria Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.7.2. Austria Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.7.3. Austria Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Coronary Stent Market Size and Forecast, By Type (2024-2032)
6.4.8.2. Rest of Europe Coronary Stent Market Size and Forecast, By End User (2024-2032)
6.4.8.3. Rest of Europe Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7. Asia Pacific Coronary Stent Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
7.1. Asia Pacific Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.2. Asia Pacific Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.3. Asia Pacific Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4. Asia Pacific Coronary Stent Market Size and Forecast, by Country (2024-2032)
7.4.1. China
7.4.1.1. China Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.1.2. China Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.1.3. China Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.2. S Korea
7.4.2.1. S Korea Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.2.2. S Korea Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.2.3. S Korea Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.3. Japan
7.4.3.1. Japan Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.3.2. Japan Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.3.3. Japan Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.4. India
7.4.4.1. India Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.4.2. India Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.4.3. India Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.5. Australia
7.4.5.1. Australia Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.5.2. Australia Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.5.3. Australia Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.6. Indonesia
7.4.6.1. Indonesia Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.6.2. Indonesia Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.6.3. Indonesia Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.7. Malaysia
7.4.7.1. Malaysia Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.7.2. Malaysia Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.7.3. Malaysia Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.8. Philippines
7.4.8.1. Philippines Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.8.2. Philippines Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.8.3. Philippines Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.9. Vietnam
7.4.9.1. Vietnam Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.9.2. Vietnam Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.9.3. Vietnam Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.10. Thailand
7.4.10.1. Thailand Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.10.2. Thailand Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.10.3. Thailand Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
7.4.11. Rest of Asia Pacific
7.4.11.1. Rest of Asia Pacific Coronary Stent Market Size and Forecast, By Type (2024-2032)
7.4.11.2. Rest of Asia Pacific Coronary Stent Market Size and Forecast, By End User (2024-2032)
7.4.11.3. Rest of Asia Pacific Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
8. Middle East and Africa Coronary Stent Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
8.1. Middle East and Africa Coronary Stent Market Size and Forecast, By Type (2024-2032)
8.2. Middle East and Africa Coronary Stent Market Size and Forecast, By End User (2024-2032)
8.3. Middle East and Africa Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
8.4. Middle East and Africa Coronary Stent Market Size and Forecast, by Country (2024-2032)
8.4.1. South Africa
8.4.1.1. South Africa Coronary Stent Market Size and Forecast, By Type (2024-2032)
8.4.1.2. South Africa Coronary Stent Market Size and Forecast, By End User (2024-2032)
8.4.1.3. South Africa Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
8.4.2. GCC
8.4.2.1. GCC Coronary Stent Market Size and Forecast, By Type (2024-2032)
8.4.2.2. GCC Coronary Stent Market Size and Forecast, By End User (2024-2032)
8.4.2.3. GCC Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
8.4.3. Nigeria
8.4.3.1. Nigeria Coronary Stent Market Size and Forecast, By Type (2024-2032)
8.4.3.2. Nigeria Coronary Stent Market Size and Forecast, By End User (2024-2032)
8.4.3.3. Nigeria Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
8.4.4. Rest of ME&A
8.4.4.1. Rest of ME&A Coronary Stent Market Size and Forecast, By Type (2024-2032)
8.4.4.2. Rest of ME&A Coronary Stent Market Size and Forecast, By End User (2024-2032)
8.4.4.3. Rest of ME&A Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
9. South America Coronary Stent Market Size and Forecast by Segmentation (by Value in USD Bn) (2024-2032)
9.1. South America Coronary Stent Market Size and Forecast, By Type (2024-2032)
9.2. South America Coronary Stent Market Size and Forecast, By End User (2024-2032)
9.3. South America Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
9.4. South America Coronary Stent Market Size and Forecast, by Country (2024-2032)
9.4.1. Brazil
9.4.1.1. Brazil Coronary Stent Market Size and Forecast, By Type (2024-2032)
9.4.1.2. Brazil Coronary Stent Market Size and Forecast, By End User (2024-2032)
9.4.1.3. Brazil Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
9.4.2. Argentina
9.4.2.1. Argentina Coronary Stent Market Size and Forecast, By Type (2024-2032)
9.4.2.2. Argentina Coronary Stent Market Size and Forecast, By End User (2024-2032)
9.4.2.3. Argentina Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
9.4.3. Rest of South America
9.4.3.1. Rest of South America Coronary Stent Market Size and Forecast, By Type (2024-2032)
9.4.3.2. Rest of South America Coronary Stent Market Size and Forecast, By End User (2024-2032)
9.4.3.3. Rest of South America Coronary Stent Market Size and Forecast, By Biomaterial (2024-2032)
10. Company Profile: Key Players
10.1. Abbott Laboratories (U.S.)
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Recent Developments
10.2. Boston Scientific Corporation (U.S.)
10.3. Medtronic plc (Ireland, operates heavily in the U.S.)
10.4. C. R. Bard, Inc. (U.S.)
10.5. Cook Medical (U.S.)
10.6. BD (Becton, Dickinson and Company) (U.S.)
10.7. Stryker Corporation (U.S.)
10.8. Elixir Medical Corporation (U.S.)
10.9. InspireMD (U.S.)
10.10. Micell Technologies, Inc. (U.S.)
10.11. Reva Medical, Inc. (U.S.)
10.12. XTENT, Inc. (U.S.)
10.13. BIOTRONIK SE & Co. KG (Germany)
10.14. B. Braun Melsungen AG (Germany)
10.15. STENTYS SA (France)
10.16. Translumina GmbH (Germany)
10.17. Eurocor GmbH (Germany)
10.18. amg International GmbH (Germany)
10.19. Arterial Remodeling Technologies (France)
10.20. Aachen Resonance GmbH (Germany)
10.21. eucatech AG (Germany)
10.22. Fortimedix B.V. (Netherlands)
10.23. Veryan Medical (UK)
10.24. Terumo Corporation (Japan)
10.25. MicroPort Scientific Corporation (China)
10.26. Biosensors International Group, Ltd. (Singapore)
10.27. Lepu Medical Technology (Beijing) Co., Ltd. (China)
10.28. Meril Life Sciences Pvt. Ltd. (India)
10.29. Medinol Ltd. (Israel)
11. Key Findings
12. Analyst Recommendations
13. Coronary Stents Market: Research Methodology
